Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Rheumatoid Arthritis

Five arthritis myths that everyone needs to stop believing

Rheumatoid arthritis isn't just aching joints, and it can affect people of any age.

Daily Record

Rheumatoid Arthritis Awareness Week: 5 myths about the autoimmune disease everyone needs to stop believing

It isn’t just aching joints, and it can affect people of any age. Lisa Salmon busts some common myths about rheumatoid arthritis.

The Independent UK

'Arthritis breakthrough in hunt for baldness cure to be available soon'

The pill was previously licensed for treatment of rheumatoid arthritis but during the pandemic its licence was extended to the treatment of hospitalised Covid-19 patients - and it had a surprising impact for those suffering from alopecia areata

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Overturning Roe leaves people with autoimmune conditions in danger

People with inflammatory arthritis like rheumatoid arthritis are having trouble getting methotrexate in the wake of abortion bans.

Inverse

Arthritis symptoms and three best drinks proven to reduce inflammation

If managed poorly, arthritis pain can impact a person's day-to-day life.

Daily Record

Arthritis symptoms: 3 best drinks proven to help reduce painful inflammation

Arthritis is a painful condition caused by high levels of inflammation in the body. Certain drinks, however, are thought to able able to reduce this inflammation and help with symptoms

Daily Mirror

Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock

Olumiant (baricitinib), a Janus kinase (JAK) inhibitor, was developed by Incyte Corp (NASDAQ:INCY) and launched in collaboration with Eli Lilly And Co (NYSE:LLY), received FDA approval for hair loss disorder known as alopecia areata (AA). Olumiant was first approved for the treatment of rheumatoid arthritis (RA) in 2018. The above nod is expected to…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer To Sell 23 Patented Drugs, Vaccines At Lower Prices To Poorer Countries

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…

Benzinga

Treatment for finger-bending disease may be ‘gamechanger’

Clinical trial seems to show Dupuytren’s disease reversed by rheumatoid arthritis drug

The Guardian - UK

AIIMS hints at new Covid complication

NEW DELHI: In the last few months, AIIMS has come across at least 30 patients who developed symptoms associated with autoimmune diseases such as rheumatoid arthritis and Sjogren’s syndrome within weeks of getting Covid-19.

The Times of India

Rheumatoid arthritis symptoms 'improved' by cutting out certain food in new study

New findings report that going vegan helped symptoms of rheumatoid arthritis.

Daily Record

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.